Levetiracetam
Levetiracetam is a distinct anticonvulsant used adjunctively for partial seizures. It is widely applied in neuroscience research to study epilepsy mechanisms and synaptic vesicle protein SV2A modulation in both in vivo and in vitro models. Rare cases of drug-induced liver injury with enzyme elevations have been reported.
Product Specifications
CAS Number
102767-28-2
Product Name Alternative
Inhibit, MGMT, HDA, Inhibitor, Levetiracetam, glioblastoma, apoptosis, antiepileptic, Calcium Channel, DNAMethyltransferase, DNMTs, DNA Methyltransferase, DNA MTases, DNA methyltransferase (DNMT), chemosensitizer, CalciumChannel, SIB-S1, Temozolomide, SV2A, synaptic, Synaptic vesicle glycoprotein 2A, protein, UCB L 059, UCB L059, UCB L-059, vesicle
Field of Research
Cell Biology
Purity
>98%
Bioactivity
Anticonvulsant
Form
Powder
Solubility
Soluble in DMSO (up to at least 25 mg/ml)
Smiles
CC[C@H] (N1CCCC1=O) C (N) =O
Molecular Formula
C29H14N2O2
Molecular Weight
170.21
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
2 (S) - (2-Oxopyrrolidin-1-yl) butyramide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
